VEGFA and cancer: Since a possible interplay between angiogenesis and immune-checkpoints has lately been evoked as a novel strategy to improve the success of cancer treatments, we ought to evaluate the potential co-expression of VEGF-A with the immune checkpoint HLA-G/ILT4.